OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology
Wilfried Müllens, Pieter Martens, Jeffrey M. Testani, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 4, pp. 603-619
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
Chiadi E Ndumele, Janani Rangaswami, Sheryl L. Chow, et al.
Circulation (2023) Vol. 148, Iss. 20, pp. 1606-1635
Open Access | Times Cited: 310

Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology
Marco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 6, pp. 776-791
Open Access | Times Cited: 95

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure
Zachary L. Cox, Sean P. Collins, Gabriel A. Hernandez, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 14, pp. 1295-1306
Closed Access | Times Cited: 39

2024 update in heart failure
Alberto Beghini, Antonio Maria Sammartino, Z. Papp, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 28

Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
О. М. Драпкина, А. V. Kontsevaya, А. М. Калинина, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 23, Iss. 3, pp. 3696-3696
Open Access | Times Cited: 14

Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC
Marco Metra, Marianna Adamo, Daniela Tomasoni, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 1115-1131
Open Access | Times Cited: 36

Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from the EMPEROR‐Preserved trial
Abhinav Sharma, João Pedro Ferreira, Faı̈ez Zannad, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 8, pp. 1337-1348
Open Access | Times Cited: 32

Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts
Nicolas Girerd, Christophe Leclercq, Olivier Hanon, et al.
Revista Española de Cardiología (English Edition) (2023) Vol. 76, Iss. 10, pp. 813-820
Open Access | Times Cited: 30

Pre-treatment bicarbonate levels and decongestion by acetazolamide: the ADVOR trial
Pieter Martens, Frederik H. Verbrugge, Jeroen Dauw, et al.
European Heart Journal (2023) Vol. 44, Iss. 22, pp. 1995-2005
Open Access | Times Cited: 29

Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases
Ziwei Zhou, Meijing Li, Zekuan Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118506-118506
Closed Access | Times Cited: 7

Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial
Daniela Tomasoni, Beth A. Davison, Marianna Adamo, et al.
Journal of Cardiac Failure (2023) Vol. 30, Iss. 4, pp. 525-537
Open Access | Times Cited: 16

The effect of kidney function on guideline‐directed medical therapy implementation and prognosis in heart failure with reduced ejection fraction
Fanni Bánfi‐Bacsárdi, Dávid Pilecky, Máté Vámos, et al.
Clinical Cardiology (2024) Vol. 47, Iss. 2
Open Access | Times Cited: 6

Konsensuspapier zum Management kardiovaskulärer Erkrankungen bei chronischer Nierenkrankheit
Katharina Marx-Schütt, Ulrich Kintscher, Johannes B. Dahm, et al.
Deleted Journal (2025)
Closed Access

Counteracting the Mechanisms of Heart Failure is the Most Effective Way to Decongest Patients while Improving Outcomes
Jelena Čelutkienė, Alexandre Mebazaa, Jan Biegus, et al.
Cardiac failure review (2025) Vol. 11
Open Access

The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure
Simone Pasquale Crispino, Andrea Segreti, Vincenzo Nafisio, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 608-608
Open Access

Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry
Marta Cobo Marcos, Rafael de la Espriella, Jara Gayán Ordás, et al.
Revista Española de Cardiología (English Edition) (2023) Vol. 77, Iss. 1, pp. 50-59
Closed Access | Times Cited: 14

Early changes in renal function during rapid up‐titration of guideline‐directed medical therapy following an admission for acute heart failure
Jozine M. ter Maaten, Alexandre Mebazaa, Beth A. Davison, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 12, pp. 2230-2242
Open Access | Times Cited: 12

Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice
Wilfried Müllens, P. Christian Schulze, Julian Westphal, et al.
European Heart Journal (2023) Vol. 44, Iss. 24, pp. 2159-2169
Open Access | Times Cited: 10

Serial direct sodium removal in patients with heart failure and diuretic resistance
Veena S. Rao, Juan B. Ivey‐Miranda, Zachary L. Cox, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 5, pp. 1215-1230
Closed Access | Times Cited: 3

Renal Mechanisms of Diuretic Resistance in Congestive Heart Failure
Norbert Lameire
Kidney and Dialysis (2023) Vol. 3, Iss. 1, pp. 56-72
Open Access | Times Cited: 9

Evolutions in Combined Heart-Kidney Transplant
Rashmi Jain, M. Kittleson
Current Heart Failure Reports (2024) Vol. 21, Iss. 2, pp. 139-146
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top